DBV Technologies DBVT
NASDAQ DBVT
$13.47 -0.23 (-1.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

DBV Technologies (DBVT) Treasury Shares (2019 - 2026)

DBV Technologies (DBVT) posted Treasury Shares of $800000.0 for Q2 2026, down 20.0% sequentially from $1.0 million in Q1 2026, and down 35.38% YoY from $1.2 million in Q2 2025.

Analysis

DBV Technologies (DBVT) Treasury Shares (2019 - 2026) Analysis & Trends

DBV Technologies has reported Treasury Shares for 8 years, with the latest figure at $800000.0 in Q2 2026.

  • Quarterly Treasury Shares fell 35.38% year-over-year to $800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $800000.0 (down 35.38% YoY) and the FY2025 annual result came in at $800000.0, down 38.88% from the prior year.
  • Treasury Shares fell to $800000.0 in Q2 2026 per DBVT's latest filing, from $1.0 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $9.9 million in Q2 2026 and troughed at $74680.0 in Q4 2025.
  • A 5-year average of $2.4 million and a median of $2.0 million in 2023 frame the typical range for Treasury Shares.
  • The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 75.18% in 2022, then slumped 38.88% in 2025.
  • Over 5 years, Treasury Shares stood at $1.1 million in 2022, then rose by 13.89% to $1.3 million in 2023, then climbed by 3.64% to $1.3 million in 2024, then slumped by 38.88% to $800000.0 in 2025, then changed by 0.0% to $800000.0 in 2026.
  • According to Business Quant data, Treasury Shares over the past three periods registered $800000.0, $1.0 million, and $800000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 DBV Technologies 5.88 Bn 5.70 Bn - 146,321.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 800,000.00
Jun 30, 2026 146,321.00
Jun 30, 2026 146,321.00
Jun 30, 2026 800,000.00
Mar 31, 2026 128,068.00
Mar 31, 2026 1.00 Mn
Mar 31, 2026 1.00 Mn
Mar 31, 2026 128,068.00
Dec 31, 2025 800,000.00
Dec 31, 2025 74,680.00
Dec 31, 2025 74,680.00
Dec 31, 2025 800,000.00
Sep 30, 2025 1.12 Mn
Sep 30, 2025 159,651.00
Sep 30, 2025 159,651.00
Sep 30, 2025 1.12 Mn
Jun 30, 2025 210,169.00
Jun 30, 2025 1.24 Mn
Jun 30, 2025 210,169.00
Jun 30, 2025 1.24 Mn